Key points are not available for this paper at this time.
BACKGROUND AND AIMS: Crohn's disease CD is a chronic, systemic inflammatory disease characterised by periods of remission and flare-ups. It has been associated with a disturbed gastrointestinal barrier function, an increase in the transport of luminal contents into the tissue, and lower immune tolerance. METHODS: Peripheral blood samples were collected from healthy controls and 33 adult active flare-up CD patients. We classified patients as onset or relapse flare-up subjects, according to the days of disease evolution. Plasma levels of lipopolysaccharide-binding protein LBP, fatty acid-binding proteins FABP, and antibodies against bacterial lysates, interferons IFN and interleukin-6 IL6 were measured by enzyme-linked immunosorbent assay ELISA in each group of patients. RESULTS: Onset CD patients had higher plasma levels of LBP 57.32 ± 38.86 vs 30.22 ± 9.80 µg/ml and IFNα 1.25 ± 0.23 vs 0.95 ± 0.36 log10pg/ml and lower levels of immunoglobulins G and A IgG and IgA antibodies against bacterial lysates than relapse CD patients. We also observed a subgroup of onset patients with the highest levels of LBP. In this subgroup, LBP correlated negatively with C-reactive protein CRP. Onset and relapse CD patients had similar levels of FABP6 and FABP2, though LBP and FABP6 correlated positively only in relapse patients. In relapse patients, anti-E coli IgG antibodies correlated positively with systemic IL6 and IFNα levels. CONCLUSIONS: Our findings suggest that onset and relapse flare-ups in adult CD patients are related to different systemic immune-related bacterial events. Characterising these differences may provide insights into the aetiology of Crohn's disease, and would help in the selection of appropriate therapies.
Cantó et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: